Back to search results

An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

Abroad (travel likely)RecruitingPHASE3

Conditions

Hemophilia B

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russia

    Contact: Study coordinator (Alexander Korobkin) · chelokb@mail.ru · +7 (351) 749-37-27

  • Federal State Budgetary Organization of Science "Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency", Kirov, Russia

    Contact: Study coordinator (Margarita Timofeeva) · niigpk@fmbamail.ru · +7 (8332) 25 59 19

  • Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Clinical Diagnostics for Hematology and Hemostasis Disorders), Moscow, Russia

    Contact: Study coordinator (Nadezhda Zozulya) · director@blood.ru · +7 (800) 775 05 82

  • Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Traumatology and Reconstructive and Restorative Orthopedics for Patients with Hemophilia), Moscow, Russia

    Contact: Study coordinator (Vladimir Zorenko) · director@blood.ru · +7 (800) 775 05 82

  • Federal Budgetary Institution "Moscow City Clinical Hospital named after S. P. Botkin", Moscow, Russia

    Contact: Study coordinator (Vadim Ptushkin) · glavbotkin@zdrav.mos.ru · +7 (499) 490 03 03

  • State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russia

    Contact: Study coordinator (Tatyana Pospelova) · gnokb@oblmed.nsk.ru · +7 (383) 315 99 99

  • State budgetary healthcare institution Leningrad Regional Clinical Hospital, Saint Petersburg, Russia

    Contact: Study coordinator (Sergey Voloshin) · lokb@47lokb.ru · +7 (812) 670 18 88

  • Russian Research Institute of Hematology and Transfusiology Federal State Institution of Federal Medical and Biological Agency, Saint Petersburg, Russia

    Contact: Study coordinator (Andrey Garifullin) · bloodscience@mail.ru · +7 (812) 309 79 81

  • Almazov National Medical Research Centre, Saint Petersburg, Russia

    Contact: Study coordinator (Vladimir Ivanov) · pmu@almazovcentre.ru · +7 (812) 702 37 16

  • Federal State Budgetary Educational Institution of Higher Education "Samara State Medical University" of the Ministry of Healthcare of the Russian Federation, Samara, Russia

    Contact: Study coordinator (Igor Davydkin) · info@samsmu.ru · +7 (846) 374 91 00

  • Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry of Healthcare of the Russian Federation, Ufa, Russia

    Contact: Study coordinator (Bulat Bakhirov) · bashsmu@yandex.ru · +7 (347) 272 41 73

  • King Chulalongkorn Memorial Hospital, Bangkok, Thailand

    Contact: Study coordinator (Ponlapat Rojnuckarin) · ponlapat.r@chula.ac.th · 6685-911-521

  • Ramathibodi Hospital, Bangkok, Thailand

    Contact: Study coordinator (Pantep Angchaisuksiri) · pantep.ang@mahidol.ac.th

  • Siriraj Hospital, Bangkok, Thailand

    Contact: Study coordinator (Yingyong Chinnathammamit) · dryingyong@gmail.com · 6681-426-4252
Study leads

  • Arina Arina V Zinkina-Orikhan

    Study Director

    Biocad

View source on ClinicalTrials.gov(opens in a new tab)